https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aVYC-2739525&symbol=VYC®ion=C
Vanity Capital CEO Miller dies, Segounis appointed CEO
2019-04-02 14:09 ET - News Release
Mr. Nicholas Segounis reports
VANITY CAPITAL INC. REPORTS ON THE PASSING OF HARRY MILLER, C.E.O. AND DIRECTOR
Vanity Capital Inc.'s Harry Miller, the chief executive officer and director of the company, passed away last week. The board has appointed Nicholas Segounis as CEO.
Mr. Miller was born in Vancouver, B.C. He went to King Edward Elementary School where he formed life-long friendships. Mr. Miller obtained his bachelor of commerce in manufacturing at the University of British Columbia in 1957, and he worked in several different industries which eventually led him to a career in the stock market. Mr. Miller was instrumental during his career in listing and raising capital for companies on the TSX Venture Exchange, Toronto Stock Exchange, Nasdaq Stock Market, American Stock Exchange and New York Stock Exchange. He had a love of learning, passion for collaborating and a track record of building companies that were successful. His entrepreneurial spirit and business acumen created value and a loyal shareholder base.
Mr. Miller built deep and lasting relationships and had a way of making people feel as if they had been heard and that they mattered. His connections with others was real, genuine and long lasting. A promise made is a promise kept was a trade mark of Mr. Miller's, and he displayed this quality in his business and personal life. He was the quintessential people person.
Nicholas Segounis, CEO and president commented: "Harry was one in a million. His word was his bond, and he led his life in the public markets with integrity, commitment and concern for what was best for his shareholders. Vanity was very fortunate to have his leadership and the benefit of his influence. I personally was honored to work with him and to have had his friendship over the years."
Mr. Miller was working toward a reverse-merger transaction with XynaRx Pharmaceuticals Corp. He was very excited about the future of Vanity and the potential value XynaRx would bring to shareholders. The board is committed to Mr. Miller's vision and fulfilling the mandate received from Vanity shareholders at the special meeting held on March 21, 2019, to complete the XynaRx business combination.
The board extends its deepest condolences to Mr. Miller's wife of 42 years Carol Miller, the Miller family, and Mr. Miller's many friends. He will be truly missed.
About Vanity
Vanity is currently a TSX-V listed junior exploration company. Vanity staked 69 claims in Feb., 2017, covering approximately 1,000 acres in the Phillips township, Kenora district, Ont. Vanity is pursuing a strategic alternative to enhance shareholder value through the arm's-length business transaction with XynaRx.
About XynaRx
XynaRx is a privately held British Columbia incorporated company focused on incorporating cannabidiol in over-the-counter healthcare products and generic medications. XynaRx intends to manufacture in-house and distribute its products in global markets. Management of XynaRx has developed a pipeline to introduce 15 OTC products and generic medications with CBD as an active ingredient over the next five years. Research and development will be conducted in-house for incorporating CBD in the 15 XynaRx products and for conducting human trials.
Trading halt
The shares of Vanity are currently halted from trading, and the trading of shares of Vanity is expected to remain halted until delisted from the TSX-V and completion of the proposed transaction with XynaRx or its termination. There can be no assurance that the proposed transaction, as previously announced on March 14, 2019, will be completed as proposed or at all.
We seek Safe Harbor.
© 2019 Canjex Publishing Ltd. All rights reserved.